## **Core Concept**
The question pertains to the vertical transmission of HIV, which refers to the transmission of HIV from mother to child during pregnancy, childbirth, or breastfeeding. The administration of prophylaxis aims to reduce this risk.

## **Why the Correct Answer is Right**
The correct answer, ****, implies that with proper prophylaxis, the risk of mother-to-child transmission (MTCT) of HIV can be significantly reduced to less than 2%. Effective prophylaxis typically involves antiretroviral therapy (ART) for the pregnant woman, which can include a combination of drugs to suppress the viral load, and for the newborn, which may include antiretroviral drugs given shortly after birth. This approach is supported by guidelines from various health organizations, including the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC).

## **Why Each Wrong Option is Incorrect**
- **Option A: > 20%**: This option suggests a high risk of transmission despite prophylaxis, which is not accurate with current guidelines and treatments. Without any intervention, the risk of MTCT can range from 15% to 45%, but with effective prophylaxis, this risk is significantly lowered.
- **Option B: 5-10%**: While this range might seem plausible for certain contexts without optimal prophylaxis or with drug resistance, it overestimates the risk when effective prophylactic measures are in place.
- **Option D: > 50%**: This option grossly overestimates the risk of vertical transmission, even without any prophylaxis.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the risk of mother-to-child transmission of HIV can be reduced to less than 2% with appropriate antiretroviral prophylaxis. This underlines the importance of routine HIV testing in pregnancy and the initiation of ART for all pregnant women living with HIV, regardless of their CD4 cell count or clinical symptoms.

## **Correct Answer:** . **< 2%**